# Braintree, A part of SEBELA Pharmaceuticals, Holbrook, MA – FDA Inspections

Source: https://www.keypedia.com/companies/braintree-a-part-of-sebela-pharmaceuticals/e32fa961-98ff-4606-8883-8c382bf240e2

> Inspection records and compliance data for Braintree, A part of SEBELA Pharmaceuticals in Holbrook, Massachusetts. 7 FDA inspections on record (1 OAI), 1 Form 483, last inspected March 07, 2025.

---

## Details

- Name: Braintree, A part of SEBELA Pharmaceuticals
- FEI Number: 1000513636
- Address Line 1: 270 Centre St
- City: Holbrook
- State: Massachusetts
- Zip Code: 02343
- Country Name: United States
- Address: 270 Centre St, Holbrook, Massachusetts 02343, United States
- Country: United States

## Related Documents

- FDA Inspection 1261728 - Braintree, A part of SEBELA Pharmaceuticals - 2025-03-07 — source: FDA, date: March 7, 2025
- FDA Inspection 1261728 - Braintree, A part of SEBELA Pharmaceuticals - 2025-03-07 — classification: No Action Indicated (NAI), source: FDA, date: March 7, 2025
- [FDA Inspection 1042622 - Braintree, A part of SEBELA Pharmaceuticals - 2018-02-28](https://www.keypedia.com/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/717fe323-8916-49e3-b346-16040875b8a5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 28, 2018
- FDA Inspection 858979 - Braintree, A part of SEBELA Pharmaceuticals - 2013-12-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 13, 2013
- FDA Inspection 814842 - Braintree, A part of SEBELA Pharmaceuticals - 2013-01-14 — classification: No Action Indicated (NAI), source: FDA, date: January 14, 2013
- [FDA Inspection 707123 - Braintree, A part of SEBELA Pharmaceuticals - 2011-01-21](https://www.keypedia.com/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/2980d372-45f6-4f29-bbd3-a2e16a160b75) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 21, 2011
- [FDA Inspection 639857 - Braintree, A part of SEBELA Pharmaceuticals - 2010-01-22](https://www.keypedia.com/records/fda_inspections/braintree-a-part-of-sebela-pharmaceuticals/d29d717b-48d5-4e5e-bee4-6184a59792c0) — classification: Official Action Indicated (OAI), source: FDA, date: January 22, 2010
- FDA Inspection 587383 - Braintree, A part of SEBELA Pharmaceuticals - 2009-05-13 — classification: No Action Indicated (NAI), source: FDA, date: May 13, 2009

## Related Companies

- [InvaGen Pharmaceuticals, Inc.](https://www.keypedia.com/companies/invagen-pharmaceuticals-inc/ed84b9eb-799d-48d0-81cf-7656245b03a2)
- [GlaxoSmithKline LLC](https://www.keypedia.com/companies/glaxosmithkline-llc/66fdfcfe-6173-4e09-abb4-df089ede2996)
- [P & L Development LLC](https://www.keypedia.com/companies/p-l-development-llc/eed180a2-666b-448a-a387-2ddc3e1e9d91)
- [PharmaMax Pharmaceuticals, Ltd.](https://www.keypedia.com/companies/pharmamax-pharmaceuticals-ltd/36995055-289f-4dec-a34c-fe75a137e22b)
- [Avara Pharmaceutical Technologies, Inc.](https://www.keypedia.com/companies/avara-pharmaceutical-technologies-inc/c685fa1d-522c-462d-a1d8-f32badd44e8d)
- [HIBROW HEALTHCARE PRIVATE LIMITED](https://www.keypedia.com/companies/hibrow-healthcare-private-limited/c5de7b11-f0fd-48a0-9bf9-e7730c9dc8fe)
- [Mylan Technologies, Inc.](https://www.keypedia.com/companies/mylan-technologies-inc/130d5987-f109-4e1e-bc68-d11396d48e70)
- [DPT Laboratories Ltd.](https://www.keypedia.com/companies/dpt-laboratories-ltd/3b2d6611-9567-4aa0-8e8c-25e1e0a1714e)
- [Cyndea Pharma](https://www.keypedia.com/companies/cyndea-pharma/679f2632-78a4-4dbb-be12-c9d038fb4941)
- [Eisai Manufacturing Limited](https://www.keypedia.com/companies/eisai-manufacturing-limited/b46d49f1-76cf-4005-b60e-f75ff775f9f9)